Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JBJ-09-063 |
Trade Name | |
Synonyms | JBJ-063 |
Drug Descriptions |
JBJ-09-063 is a fourth-generation allosteric EGFR inhibitor with activity against select EGFR resistance mutations, which potentially results in reduced cell proliferation and tumor growth (PMID: 35422503). |
DrugClasses | EGFR Inhibitor 4th gen 16 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gefitinib + JBJ-09-063 | Gefitinib JBJ-09-063 | 0 | 0 |
JBJ-09-063 | JBJ-09-063 | 0 | 0 |
JBJ-09-063 + Osimertinib | JBJ-09-063 Osimertinib | 0 | 0 |